FdaApplication
ANDA 083177
Identifiers
- fda_app_no: ANDA083177
Properties
| Property | Value |
|---|---|
| applicant_name | IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA |
| application_type | ANDA |
| approval_date | 2024-09-19 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | 50MG | TABLET;ORAL |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | 12.5MG | TABLET;ORAL |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | 25MG | TABLET;ORAL |
3 products